Clinical update on AMG 420, an anti-BCMA BiTE®
PharmaTalkRadio1 Nov 2019

Clinical update on AMG 420, an anti-BCMA BiTE®

In this talk, recorded at the 5th annual IO360° Summit, Dr Alex Minella, Amgen, provides a clinical update on AMG 420, an anti-BCMA BiTE® This talk addresses the: Summary of IND enabling preclinical studiesFirst-in-human trial designFirst-in-human trial data (safety, efficacy) Save the date for the 6th annual Immuno-Oncology 360° Summit on February 26-28, 2020 at the Crowne Plaza Times Square in New York City. Learn more at www.io360summit.com

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(461)

Populært innen Vitenskap

fastlegen
tingenes-tilstand
rekommandert
jss
sinnsyn
liberal-halvtime
forskningno
tomprat-med-gunnar-tjomlid
fjellsportpodden
rss-overskuddsliv
villmarksliv
dekodet-2
rss-paradigmepodden
rss-inn-til-kjernen-med-sunniva-rose
rss-zahid-ali-hjelper-deg
kvinnehelsepodden
rss-rekommandert
hva-er-greia-med
nevropodden
aldring-og-helse-podden